• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-HT4 受体持续促进 APP 切割的非淀粉样蛋白途径,并与 ADAM10 相互作用。

5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

机构信息

CNRS, UMR-5203, Institut de Génomique Fonctionnelle, F-34000 Montpellier, France.

出版信息

ACS Chem Neurosci. 2013 Jan 16;4(1):130-40. doi: 10.1021/cn300095t. Epub 2012 Oct 13.

DOI:10.1021/cn300095t
PMID:23336052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3547471/
Abstract

In addition to the amyloidogenic pathway, amyloid precursor protein (APP) can be cleaved by α-secretases, producing soluble and neuroprotective APP alpha (sAPPα) (nonamyloidogenic pathway) and thus preventing the generation of pathogenic amyloid-β. However, the mechanisms regulating APP cleavage by α-secretases remain poorly understood. Here, we showed that expression of serotonin type 4 receptors (5-HT(4)Rs) constitutively (without agonist stimulation) induced APP cleavage by the α-secretase ADAM10 and the release of neuroprotective sAPPα in HEK-293 cells and cortical neurons. This effect was independent of cAMP production. Interestingly, we demonstrated that 5-HT(4) receptors physically interacted with the mature form of ADAM10. Stimulation of 5-HT(4) receptors by an agonist further increased sAPPα secretion, and this effect was mediated by cAMP/Epac signaling. These findings describe a new mechanism whereby a GPCR constitutively stimulates the cleavage of APP by α-secretase and promotes the nonamyloidogenic pathway of APP processing.

摘要

除淀粉样蛋白生成途径外,淀粉样前体蛋白(APP)还可被α-分泌酶切割,产生可溶性且具有神经保护作用的 APP α(sAPPα)(非淀粉样蛋白生成途径),从而防止致病性淀粉样β的产生。然而,调节α-分泌酶切割 APP 的机制仍知之甚少。本研究表明,5-羟色胺 4 型受体(5-HT4Rs)的表达可在不依赖激动剂刺激的情况下,持续诱导 HEK-293 细胞和皮质神经元中 ADAM10 介导的 APP 切割和具有神经保护作用的 sAPPα 的释放。这种效应与 cAMP 的产生无关。有趣的是,我们证明 5-HT4R 与 ADAM10 的成熟形式存在物理相互作用。激动剂刺激 5-HT4R 可进一步增加 sAPPα 的分泌,而这种作用是由 cAMP/Epac 信号介导的。这些发现描述了一种新的机制,即 GPCR 持续刺激 APP 通过 α-分泌酶的切割,并促进 APP 加工的非淀粉样蛋白生成途径。

相似文献

1
5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.5-HT4 受体持续促进 APP 切割的非淀粉样蛋白途径,并与 ADAM10 相互作用。
ACS Chem Neurosci. 2013 Jan 16;4(1):130-40. doi: 10.1021/cn300095t. Epub 2012 Oct 13.
2
Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.没食子酸辛酯通过雌激素受体介导的 ADAM10 激活显著促进 APP 的抗淀粉样蛋白形成加工。
PLoS One. 2013 Aug 15;8(8):e71913. doi: 10.1371/journal.pone.0071913. eCollection 2013.
3
Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.发动蛋白的显性负性抑制剂可增加ADAM10的表面表达及有限蛋白水解作用。
BMC Cell Biol. 2011 May 17;12:20. doi: 10.1186/1471-2121-12-20.
4
Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.淀粉样前体蛋白的组成性α-和β-分泌酶切割在神经元中部分偶联,但在常用细胞系中并非如此。
Neurobiol Dis. 2013 Jan;49:137-47. doi: 10.1016/j.nbd.2012.08.011. Epub 2012 Aug 24.
5
Cryptotanshinione upregulates alpha-secretase by activation PI3K pathway in cortical neurons.隐丹参酮通过激活皮质神经元中的 PI3K 通路而上调 α-分泌酶。
Brain Res. 2010 Aug 12;1348:165-73. doi: 10.1016/j.brainres.2010.05.083. Epub 2010 Jun 2.
6
Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.过氧化物酶体增殖物激活受体α的激活刺激了ADAM10介导的淀粉样前体蛋白的蛋白水解。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8445-50. doi: 10.1073/pnas.1504890112. Epub 2015 Jun 15.
7
Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.淀粉样前体样蛋白 2 的蛋白水解酶 ADAM10、BACE1 和 γ-分泌酶的蛋白水解裂解位点的确定。
PLoS One. 2011;6(6):e21337. doi: 10.1371/journal.pone.0021337. Epub 2011 Jun 17.
8
Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.淀粉样前体蛋白经 ADAM10 的蛋白水解切割作用促进乳腺癌的增殖和迁移。
EBioMedicine. 2018 Dec;38:89-99. doi: 10.1016/j.ebiom.2018.11.012. Epub 2018 Nov 20.
9
Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.sAPPα诱导的Akt生存途径激活需要全APP和G蛋白介导的信号传导。
Cell Death Dis. 2014 Aug 28;5(8):e1391. doi: 10.1038/cddis.2014.352.
10
ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.ADAM10 是原代神经元中淀粉样前体蛋白的生理相关、组成性的α-分泌酶。
EMBO J. 2010 Sep 1;29(17):3020-32. doi: 10.1038/emboj.2010.167. Epub 2010 Jul 30.

引用本文的文献

1
Impact of 5-HT4 Receptors on Neuron-Glial Network Activity In Vitro.5-羟色胺4受体对体外神经元-神经胶质网络活动的影响
Int J Mol Sci. 2025 Aug 9;26(16):7718. doi: 10.3390/ijms26167718.
2
Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective.阿尔茨海默病的病因假说与治疗策略:一种观点
Int J Mol Sci. 2025 Jul 20;26(14):6980. doi: 10.3390/ijms26146980.
3
New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer's Disease: A Review.利用炔丙胺衍生物抑制单胺氧化酶-B(MAO-B)治疗阿尔茨海默病的新前景:综述
ACS Omega. 2025 Jun 16;10(25):26208-26232. doi: 10.1021/acsomega.5c00134. eCollection 2025 Jul 1.
4
The interaction between neurotransmitter receptor activity and amyloid-β pathology in Alzheimer's disease.阿尔茨海默病中神经递质受体活性与β-淀粉样蛋白病理学之间的相互作用。
J Alzheimers Dis. 2025 Jul;106(2):391-409. doi: 10.1177/13872877251342273. Epub 2025 Jul 1.
5
Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless Condition.阿尔茨海默病中的5-羟色胺能调节剂:绝望状况下的一线希望
Chem Biodivers. 2025 Aug;22(8):e202403401. doi: 10.1002/cbdv.202403401. Epub 2025 Jun 3.
6
Systemic Modulators: Potential Mechanism for the 5-HT System to Mediate Exercise Amelioration in Alzheimer's Disease.全身调节剂:5-羟色胺系统介导运动改善阿尔茨海默病的潜在机制。
Aging Dis. 2024 Oct 7. doi: 10.14336/AD.2024.0834.
7
Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans.表达血清素 2C 受体的神经回路调节小鼠和人类的记忆。
Sci Adv. 2024 Jun 28;10(26):eadl2675. doi: 10.1126/sciadv.adl2675.
8
5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy.5-羟色胺4(5-HT4)受体激动剂治疗可减轻tau蛋白病PS19小鼠模型中的tau病理变化和行为缺陷。
Front Cell Neurosci. 2024 Apr 4;18:1338502. doi: 10.3389/fncel.2024.1338502. eCollection 2024.
9
Mitochondrial Interaction with Serotonin in Neurobiology and Its Implication in Alzheimer's Disease.线粒体在神经生物学中与血清素的相互作用及其在阿尔茨海默病中的意义。
J Alzheimers Dis Rep. 2023 Nov 1;7(1):1165-1177. doi: 10.3233/ADR-230070. eCollection 2023.
10
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.阿尔茨海默病是人类大脑自然老化的固有组成部分:综合视角。
Free Neuropathol. 2022 Jul 8;3:17. doi: 10.17879/freeneuropathology-2022-3806. eCollection 2022 Jan.

本文引用的文献

1
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.5-HT(6) 受体招募 mTOR 作为精神分裂症认知障碍的机制。
EMBO Mol Med. 2012 Oct;4(10):1043-56. doi: 10.1002/emmm.201201410.
2
5-HT(4) receptors, a place in the sun: act two.5-HT(4) 受体,阳光之地:第二幕。
Curr Opin Pharmacol. 2011 Feb;11(1):87-93. doi: 10.1016/j.coph.2011.01.012. Epub 2011 Feb 20.
3
Neuroprotective therapeutics for Alzheimer's disease: progress and prospects.用于治疗阿尔茨海默病的神经保护疗法:进展与展望。
Trends Pharmacol Sci. 2011 Mar;32(3):141-7. doi: 10.1016/j.tips.2010.12.007. Epub 2011 Jan 20.
4
The role of G protein-coupled receptors in the pathology of Alzheimer's disease.G 蛋白偶联受体在阿尔茨海默病病理中的作用。
Nat Rev Neurosci. 2011 Feb;12(2):73-87. doi: 10.1038/nrn2977.
5
α-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential.阿尔茨海默病中的 α-分泌酶:分子特性、调控及治疗潜力。
J Neurochem. 2011 Jan;116(1):10-21. doi: 10.1111/j.1471-4159.2010.07081.x. Epub 2010 Dec 2.
6
Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-β.维甲酸受体-α信号通路拮抗细胞内和细胞外淀粉样β的产生,并预防由淀粉样β引起的神经元细胞死亡。
Eur J Neurosci. 2010 Oct;32(8):1246-55. doi: 10.1111/j.1460-9568.2010.07426.x.
7
Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.γ-分泌酶激活蛋白是阿尔茨海默病的治疗靶点。
Nature. 2010 Sep 2;467(7311):95-8. doi: 10.1038/nature09325.
8
ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.ADAM10 是原代神经元中淀粉样前体蛋白的生理相关、组成性的α-分泌酶。
EMBO J. 2010 Sep 1;29(17):3020-32. doi: 10.1038/emboj.2010.167. Epub 2010 Jul 30.
9
SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10.SIRT1 通过激活 α-分泌酶基因 ADAM10 来抑制β-淀粉样蛋白的产生。
Cell. 2010 Jul 23;142(2):320-32. doi: 10.1016/j.cell.2010.06.020.
10
REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state.综述:γ-分泌酶抑制剂治疗阿尔茨海默病的研究进展
CNS Neurosci Ther. 2010 Oct;16(5):272-84. doi: 10.1111/j.1755-5949.2010.00164.x. Epub 2010 Jun 16.